We has demonstrated that PPIs promote PD‐L1 translocation in an array of cancer cells in vitro, and the concurrent administration of PD‐L1 inhibitors and PPIs in vivo appears to synergistically impede the progression of lung and colon cancers. The gene discussed is CD274; the disease is colonic neoplasm.